ArticleMolecular therapy oncolytics2022

A cross-reactive pH-dependent EGFR antibody with improved tumor selectivity and penetration obtained by structure-guided engineering.

Ximing Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.